A drug that costs $8 a day may be cheaper to use than an old generic that's only cost $1. Less stringent monitoring of patients on the newly approved drug is a big reason why, according to an independent analysis.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2010/11/08/131162526/pricey-new-blood-thinner-could-be-a-deal?ft=1&f=103537970
Posted
Nov 08 2010, 09:31 AM
by
NPR Blogs: Shots - Health News Blog